You're signed outSign in or to get full access.
Syncona Portfolio LTD
CIK:0001725042
Investment Adviser
$3B AUM
2 holdings
London, United Kingdom
Syncona is a life science investor focused on funding companies to turn exceptional science into transformational treatments in various therapeutic areas.
Investment Strategy
Investing in life science businesses and single or multi-asset projects to achieve superior long-term capital appreciation.
Latest 13F Filing Activity
Syncona Portfolio LTD filed their most recent 13F report on Jun 30, 2025 disclosing 2 equity positions with a total 13F market value of $39M. The fund increased holdings in Autolus Therapeutics PLC, Century Therapeutics. Syncona Portfolio LTD reduced exposure to Century Therapeutics, Autolus Therapeutics PLC.
Top Holdings
Equity Positions (2)
Industry Allocation
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+100.0%
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more